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1 Introduction
Nowadays, the main treatment for leukaemia is chemo-
therapy. This treatment is dangerous as much as it is ef-
fective, because alkylating antineoplastic agents target can-
cer cells and healthy cells at the same time.1 In addition, 
chemotherapy causes marrow depression, hence the risk 
of bacterial and viral infections. 
Phytochemicals have been shown to possess anticarcino-
genic and antimutagenic properties; thus, they can play 
an important role in lowering different types of neoplasia.2 
Natural and dietetic nutraceuticals may possess anticancer 
activities, such as carotenoids which promote gap-junc-
tional communication, in vitro, through the amplification 
of “connexin 43”, or flavonoids, which modulate xenobi-
otic detoxification in phase I and II , or vitamin E which 
inhibits protein kinase C, an essential enzyme in tumour 
progression of certain types of cancer.3
In another clinical study on Chinese herbs, ginger was sig-
nificantly associated with longer survival time of patients 
suffering from metastatic breast cancer.2 Numerous reports 
indicate that phytochemicals (e.g., cumin, red pepper, and 
ginger) can potentially prevent cancer by suppressing the 
nuclear transcription factor-κB (NF-κB) pathway that corre-
lates with cancer and many inflammatory diseases.3
This research represents continuation of the research from 
the work published in 2017. Our research aims to eluci-
date a natural treatment based on Zingiber officinale by 
maintaining the molecular compatibility present in the 
plant to eliminate or reduce the side effects. Therefore, 
the therapeutic potential of Zingiber officinale was tested 
to prevent or cure myelotoxicity or leukaemia, as well as 
leave the marrow intact. Dominant research is based on 
in vitro tests.4,5,6 The purpose of all such research was to 
cause apoptosis in malignant cells by Zingiber officinale. 
This work attempted to accomplish an in vivo test in order 
to demonstrate that the pharmacological activity is quite 
different from that of an in vitro test. 
2 Materials and methods 
2.1 Animal materials
Rabbits were kindly supplied by the Laboratory of Phar-
macotoxicology, Saidal Antibiotical of Médéa, Algeria. An 
albino race hybrid between New Zealanders and Califor-
nia – the mass of one rabbit was 1.5 kg. Three male rabbits 
in each group. Age of rabbits: 6 to 7 months.
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Lot (1): Negative control, without treatment.
Lot (2): Zingiber officinale group. These rabbits were used 
to study the influence of the chronic consumption 
of Zingiber officinale (Gavage). 
Lot (3): Positive control. Rabbits, singled out to cause bone 
marrow toxicity and/or leukaemia, by subcuta-
neously injecting 0.2 ml kg−1 of cyclohexatriene, 
three times a week.
Lot (4): Cyclohexatriene + Zingiber officinale. The con-
sumption of Zingiber officinale by mouth at 
the same time with subcutaneous injection of 
0.2 ml kg−1 cyclohexatriene three times a week.
Blood cells interval of New Zealand rabbit were: red blood 
cells (RBC) 4.5–7.0 ∙ 106/mm3, white blood cells (WBC) 
5–12 ∙ 103/mm3, and platelet (PLA) 250–750 ∙ 103/mm3.7
2.2 Plant materials 
Used was the natural extract of Zingiber officinale (import-
ed from China) taken from fresh rhizome by a mechanical 
method, and dried form of Zingiber officinale. The same 
doses were administered to Lot (2) Zingiber officinale, and 
Lot (4) cyclohexatriene + Zingiber officinale, during the ex-
periment. 
2.3 Gas chromatography–mass spectrometry (GC-MS)
This analysis is a quality control aimed to determine the 
most pharmacologically active compounds. In order to ex-
tract Zingiber officinale oil from the dried Zingiber officinale 
rhizome, acetone was used as the extraction solvent by 
maceration method. The analysis was carried out at the 
Laboratory of the Scientific Police of Algiers. Apparatus: 
GC-MS model CLARUS 500 brand Perkin-Elmer. 
2.4 GC-MS method 
The experimental conditions of the GC-MS system were 
as follows: standard non-polar column TR 5-MS capillary, 
dimension: 30 Mts, ID: 0.25 mm, film thickness: 0.25 μm. 
Flow of the mobile phase (carrier gas: He) was adjusted to 
1 ml min−1. Temperature program (oven temperature) was 
raised from 40 °C to 220 °C at 4 °C min−1, and the injection 
volume was 1 μl. Samples were run fully at a range of 20 
and 550 m/z, and the results were compared using the 
Wiley and NIST Spectral Library Search Programme.
2.5 Histology and histological stain (liver) 
The tissue was fixed with 10 % formalin, dehydrated in 
successive alcohol baths at increasing concentrations 70 % 
– 95 % – 100 %, and making of paraffin blocks using in-
clusion cassettes, then stored at +4 °C for 24 h, according 
to two studies.8,9 Cutting ribbons were produced by using 
the microtome (type 820 Rotary Microtome) set at 4 mi-
crons. Tissue was deparaffinised by hydration of the slides 
in a battery containing: 2 toluene baths, 3 alcohol baths at 
decreasing concentration: 100 % – 95 % – 70 %, 1 bath of 
distilled water. Finally, the tissues were stained with hema-
toxylin and eosin stain (H&E stain).8,9
2.6 Statistical analysis
Statistical analysis was performed using STATISTICA soft-
ware, version 10.0.1 (STATISTICA Inc, LBMPT, Médéa, Al-
geria) for Windows. Data were analysed and presented as 
means ± SD. Differences between continuous data were 
analysed using one-way ANOVA. P < 0.05 was considered 
significant.
3 Results and discussion
3.1 Haematological behaviour during one year
The collection of blood was taken from the marginal ear 
vein of the rabbit. The blood was then put into EDTA tubes, 
and the Automatic Hematology Analyser (ERMA PCE210) at 
the Hematology Laboratory, Hospital of Médéa, was used 
for the analysis, which automatically gave CBC (complete 
blood count).
The analysis was carried out every 61 days.
3.1.1 Interpretation 
The positive control Lot (3): made a leukocyte fall from 
the first three months. These values continued to fall sig-
nificantly (P < 0.005) compared to the negative control 
Lot (1), until they had a severe leukopenia by the end 
of the experiment (Figs. 1(A) and 1(D)).The number of 
leukocytes fell below 2500/mm3 for the positive control 
Lot (3). These values fell below the limit of healthy rabbits 
(5–12 ∙ 103/mm3).7 These values continued to fall until the 
end of the experiment, when a slight increase was noticed 
(Figs. 1(A) and 1(D)), indicating that the cyclohexatriene 
had affected the cell precursors.
The dominant side effect of the cyclohexatriene is myelo-
toxicity. This can harm the bone marrow, leading to anae-
mia and leucopoenia. Animals with aplastic anaemia often 
develop myelodysplasia, leading in general to acute mye-
loid leukaemia.8
It is essential to understand the metabolism of cyclohex-
atriene, in order to determine the mechanisms of toxicity. 
The metabolism of cyclohexatriene occurs mainly in the 
liver, although metabolism in the bone marrow is believed 
to play a crucial role in the myelotoxicity of cyclohex-
atriene, because bone marrow is rich in peroxidase activi-
ty. It is likely that oxidative stress contributes to the toxicity 
of cyclohexatriene in a way that the initial metabolic step 
is the oxidation of cyclohexatriene to an epoxide (i.e., d. 
cyclohexatriene oxide), which is catalysed primarily by 
CYP2E1 liver.8
For Lot (4) cyclohexatriene + Zingiber officinale, it was ob-
served that rabbits surmount the action of cyclohexatriene, 
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as cellular parameters of blood were kept in the rabbits’ 
hygienic interval, and we can save this resistance from 
the initial 3 months, so ginger thwarted myelotoxicity of 
cyclohexatriene in spite of the low portion administrated 
in this period hundredth LD0 of the natural extract (1/100 
LD0: Adaptation of rabbits).10
N.B.: LD0 (NOAEL) No Observed Adverse Effect Level is 
the most elevated portion that causes no lethality and no 
mortality.7 It is 75 g kg−1 of fresh rhizome and 7.5 g kg−1 of 
powdered Zingiber officinale.11 (1/x) LD0: in order to find 
the lower dose that gives the best activity.10
In the next three months in which the rabbits received a 
high portion of ginger, 1/35 LD0 of the natural extract (study 
of the preventive impact), it was observed that the amount 
of leukocytes (WBC) increased significantly (P < 0.005), in-
dicating a safe upgrade prompted by ginger (Figs. 1(A) and 
1(D)).
From that point forward, it was attempted to lower the 
portion of ginger to 1/70 LD0 (natural extract) for three 
months, with the end goal to discover the connection be-
tween dose and activity accountable for the decline in leu-
kocytes. However, the values failed to exceed the lower 
furthest reaches of the hygienic interval.10
From there on, the two forms of ginger (fresh natural ex-
tract + powder) were combined in a portion of 1/35 LD0, 
allowing for the synergistic impact of the two plant forms, 
where the blood parameters were settled in the rabbits’ 
hygienic interval.10
For negative control (Lot (1)) and Zingiber officinale group 
(Lot (2)) (Fig. 1(A)), a relatively indistinguishable leukocyte 
improvement was observed, indicating that ginger, in var-
ious dosages, had no haematological unsettling influence, 
on the first supposition that ginger action occurs particular-
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Fig. 1 – (A) Curve representing the kinetics of white blood cells during the experiment. (B) Curve representing the kinetics of red 
blood cells during the experiment. (C) Curve representing the kinetics of platelet during the experiment. (D) Curve represent-
ing the kinetics of white blood cells during the experiment (positive control and Lot (4)). (E) Histogram represents the average 
level of white blood cells during the experiment.
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3.2 Evaluation of the blood smear after bone 
marrow depression (positive control Lot (3)), and 
cyclohexatriene + Zingiber officinale group, Lot (4) 
Morphological perception of polynuclear neutrophils 
(PNN) in all rabbits of this group, Lot (3), demonstrates a 
hyper poisonous granulation (Figs. 2(A) and 2(B)). This in-
dication affirms that cyclohexatriene influenced the bone 
marrow by practicing its mutagenic impact and, along 
these lines, we recorded serious pancytopenia (3 lined 
falling WBC, RBC, PLA). This cell fall takes esteems under-
neath the lower interval value (Figs. 1(A), 1(B), and 1(C)). 
We noticed that the group injected with cyclohexatriene 
and subjected to a ginger gavage, Lot (4), reveals cell mor-
phology flawless and non-pathogenic, in light of the fact 
that there is no indication of intoxication (Figs. 1(A), 1(D), 
and 1(E)) and (Figs. 2(C) and 2(D)). It should be pointed out 
that the 1/35 DL0 from the ginger natural extract improved 













Fig. 2 – (A) and (B): Blood smear observed by optical microsco-
py, Lot (3) positive control (×100). (C) and (D): Blood 
smear shows healthy cells, Lot (2) ginger (×100).10
3.2.1 Perception of medullary gram  
after bone marrow injury 
With the end goal to affirm the bone marrow injury, it is 
important to prepare the marrow smear. The specimen 
was taken using a sterile trocar by entering the iliac bone. 
At that point, the marrow was taken with a normal syringe 
(Fig. 3(E)). The smear demonstrates the morphology of the 
bone marrow antecedent cells.10 
3.2.2 Interpretation
There was a hypertoxic granulation in the rabbits’ marrow 
smears (positive control Lot (3)) (Figs. 3(A), 3(C), and 3(D)), 
and additionally, the observation of myelodysplasia phe-
nomena (Fig. 3(D)). Knowing these indications of myelod-
ysplasia regularly precede development of leukaemia.12,13,14 
A few rabbits from the positive control Lot (3) had excep-
tionally poor marrow as a result of extreme bone marrow 
injury (Fig. 3(B)). Later, all animals from the positive con-
trol passed on following extreme pancytopenia, even be-
fore affirming the accomplishment of rabbits’ leukaemia. 
However, the analysis revealed the dominance of acute 
leukaemia, which frequently showed as pancytopenia,15 















Fig. 3 – (A) Marrow smear: hyper toxic granulation Lot (3) Posi-
tive control. (B) Marrow smear: weak medullar smear in 
some rabbits Lot (3) positive control. (C) Marrow smear: 
hyper toxic granulation Lot (3) positive control. (D) Mar-
row smear: sign of myelodysplasia Lot (3) positive con-
trol. (E) Marrow sampling technique.10
3.3 Anatomy investigation of tissue (dissection) 
3.3.1 Liver
The microscope revealed a normal liver parenchyma in 
negative control Lot (1) (Fig. 4(A)). In the group submitted 
to chronic gavage of ginger Lot (2): the hepatic parenchyma 
showed a normal appearance, without injury (Fig. 4(B)). In 
rabbits exposed to injection of cyclohexatriene (positive 
control Lot (3)), there was a cytoplasmic cell elucidation, 
with poisonous granulation in the whole specimen. These 
indications of inebriation affirm the hepatotoxic activity of 
cyclohexatriene (Figs. 4(C) and 4(D)). It might flag the non-
appearance of tumour invasion.
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Concerning the gavage of Zingiber officinale and injection 
of cyclohexatriene in parallel, a heterogeneous appear-
ance can be seen because of ordinary liver cells, healthy in 
their greater part, and a few cells with cytoplasmic granu-
lations and elucidation (Figs. 4(E)). In this way, the progres-
sions and cell harm instigated by cyclohexatriene in posi-
tive control Lot (3), were fundamentally diminished in the 
Lot (4) by the accompanying activity of Zingiber officinale, 
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Fig. 4 – (A) Hepatic parenchyma of a healthy histological aspect 
Lot (1) negative control (×10). (B) Hepatic parenchyma 
of a healthy histological aspect Lot (2) ginger (×10). (C) 
Hepatic parenchyma cell showing an interesting clarifi-
cation in almost all tissues Lot (3) positive control (×10). 
(D) Hepatic parenchyma cell showing an interesting 
clarification in almost all tissues Lot (3) positive control 
(×40). (E) Hepatic parenchyma with few clarified cells, 
Lot (4) cyclohexatriene + ginger (fewer cells with clear 
cytoplasm) (×10).10
3.3.2 Analysis of Zingiber officinale extract with GC-MS
The gas chromatography mass spectrum GC-MS, revealed 
that acetone Zingiber officinale extract contained eight dif-
ferent molecules (Fig. 5), with a characteristic retention 
time and molecular weight of each molecule (Table 1).
Major constituents of Zingiber officinale extract identi-
fied by gas chromatography and mass spectrometry were 
β-sesquiphellandrene, curcumene, Zingiberene, and 
6-shogaol.
4 Conclusion
This investigation reveals that ginger contains a compelling 
preventive potential against the blood-harmfulness and 
hepatotoxicity initiated by cyclohexatriene. In addition, as 
cyclohexatriene fundamentally targets the bone marrow 
by causing DNA mutations that harm hematopoietic cells, 
which end up being the wellspring of expansion of can-
cer-causing cells and the beginning of leukaemia, ginger 
can protect against leukaemia and against marrow harm 
instigated by xenobiotic factor. Thus, it is obvious that gin-
ger is a compelling defender against natural factors. The 
remedial action of ginger against leukaemia should be fur-
ther investigated. 
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Fig. 5 – GC-MS spectrum of ginger acetone extract
Table 1 – Molecules composing the ginger extract obtained by 
GC-MS analysis
Molecule name Retention time ⁄ min
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SAŽETAK
Preventivna aktivnost đumbira (Zingiber officinale) u suzbijanju 
mijelotoksičnosti i hepatotoksičnosti izazvane cikloheksatrienom i  
identifikacija najaktivnijih spojeva metodom GC-MS
Khaled Otmanine,a,* Salah Hanini,b Othmane Benkortbi,b Razika Bekri,c Karim Amroun,d  
Merouane Djellal,e Sara Kohli a i Karine Oumouna-Benachour e
Cilj ove studije bio je otkriti preventivnu sposobnost Zingiber officinale u suzbijanju mijelotoksič-
nosti, leukemije i hepatotoksičnosti. Ovaj je rad većim dijelom temeljen na potkožnom ubrizga-
vanju cikloheksatriena u kuniće da bi se sintetskom strategijom izazvala bolest. Usporedno s time, 
druga skupina kunića bila je izložena injekciji cikloheksatriena u sličnim uvjetima s hranjenjem 
Zingiber officinale, gdje je otkriveno da je suprotstavljena mijelotoksičnost izazvana cikloheksatrie-
nom. Histološkim pregledom dodatno je otkriven hepatoprotektivni intenzitet Zingiber officinale. 
Najviše farmakološki aktivnih molekula Zingiber officinale prepoznato je metodom plinske kroma-
tografije–masene spektrometrije (GC-MS).
Ključne riječi 
Zingiber officinale, hepatoprotektivno djelovanje, cikloheksatrien, mijelotoksičnost, GC-MS  
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